Medication info
Sitaflo Glipizide 10/100 milligrams

Sitaflo Glipizide 10/100 milligrams

Prescription medicationTablet
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›113.4mg / 1 tabletDapagliflozin citric acid›14.7mg / 1 tablet
Manufacturer / importer
한국프라임제약(주)
Appearance
Yellow rectangular film-coated tablet
Packaging
28 tablets/box[(7 tablets/ptp x 4)], 30 tablets/box[(10 tablets/ptp x 3)]
Approval status
Active

MFDS item code 202200498 · Approved 2022.01.28 · Insurance code 663608630

Summary

Main use
Improvement of blood sugar control in type 2 diabetes
Who uses it
Adults
Adult dosage
This medication can be administered to patients receiving Sitagliptin 100 mg and Dapagliflozin 10 mg, taken once daily regardless of meals, with 1 tablet to be swallowed whole.

Ingredients

Manufacturer
한국프라임제약(주)

Efficacy & effects

Improvement of blood sugar control in type 2 diabetes

View approved original text

This medication is used in conjunction with dietary and exercise therapy to help control blood sugar levels in patients with type 2 diabetes. The two components, sitagliptin and dapagliflozin, work together to effectively lower blood sugar levels. This supports patients in maintaining more stable blood sugar control. If blood sugar control is difficult, taking this medication contributes to improving health.

Dosage and Administration

Adult dosage

This medication can be administered to patients receiving Sitagliptin 100 mg and Dapagliflozin 10 mg, taken once daily regardless of meals, with 1 tablet to be swallowed whole.

Precautions

This medication may cause severe allergic reactions, so if symptoms such as skin rash, difficulty breathing, or swelling of the lips or face occur, discontinue use immediately and consult a doctor. This medication may cause acute pancreatitis, a serious inflammation of the pancreas, so contact a doctor immediately if symptoms such as abdominal pain, vomiting, or fever arise. This medication should not be used in patients with certain genetic disorders, type 1 diabetes, or patients on dialysis. Patients with deteriorating kidney function or reduced fluid volume need dosage adjustments, and periodic monitoring of kidney function and blood pressure is required. This medication can cause hypoglycemia, so especially when taken with other hypoglycemic agents such as insulin or sulfonylureas, blood glucose levels should be closely monitored. There is an increased risk of genital infections or urinary tract infections, so if related symptoms (itching, pain, difficulty urinating, etc.) occur, consult a doctor immediately. Elderly patients or those with impaired liver function should take extra caution when using this medication and should have periodic kidney function tests. Women who are pregnant or planning to become pregnant should avoid taking this medication, and it should also be avoided during breastfeeding. This medication may require caution when driving or operating machinery, especially if symptoms of hypoglycemia occur. In case of overdose, immediate medical attention is necessary, and it is not known whether this medication can be removed by dialysis. The safety and efficacy of this medication in children have not been established, so patients under 18 years of age should not take it. Store in a place out of reach of children, and keep in the original container to maintain product quality.

Side effects and when to seek care immediately

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, paleness, severe rash with high fever, blisters, skin peeling, pain in mucous membranes of the mouth/eyes, shortness of breath or difficulty breathing, asthma attack, cough with fever and respiratory abnormality, yellowing of skin or eyes (jaundice), severe lethargy throughout the body, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urinary incontinence

Mild side effects

Headache, nasopharyngitis, upper respiratory infection, constipation, dry mouth, low back pain, pain during urination, polyuria, nocturia, vulvar itching, genital itching, increased hematocrit, decreased renal creatinine clearance at the start of treatment, dyslipidemia, increased serum creatinine, increased serum urea, weight loss, hypoglycemia, dizziness, abdominal pain, nausea, diarrhea, pruritus, myalgia, limb pain, back pain, weakness, pain, edema, foreign body sensation, facial swelling

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air contact and should be kept at a temperature between 1 and 30 degrees Celsius. Proper storage ensures the maintenance of the drug's effectiveness and prevents deterioration.

Appearance and packaging

Appearance

Yellow rectangular film-coated tablet

Package unit

28 tablets/box[(7 tablets/ptp x 4)], 30 tablets/box[(10 tablets/ptp x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.